期刊文献+

负载膀胱癌冻融抗原对树突状细胞分泌IL-12的影响 被引量:3

Effect of bladder-tumor lysate on capacity of DCs excreting IL-12
暂未订购
导出
摘要 目的探讨负载膀胱癌冻融抗原对树突状细胞(DCs)分泌IL-12的影响。方法反复冻融法获得膀胱癌细胞株BIU-87细胞抗原;联合应用重组人的GM-CSF、IL-4和TNF-α体外诱导健康志愿者DCs并负载膀胱癌肿瘤抗原;用ELISA法检测第3、6和9天培养细胞的上清液,评价DCs分泌IL-12p70的能力。结果联合应用重组人的GM-CSF、IL-4和TNF-α可在体外诱导出DCs;经ELISA方法检测,不同时期的DCs分泌IL-12的量不同,而且负载抗原DCs较未负载抗原DCs有更强的分泌能力(P<0.05)。结论IL-12p70的分泌量受DCs的成熟状态及某些刺激信号的影响,膀胱癌冻融抗原是其刺激信号之一。 [Objective] To observe the effect of bladder-tumor lysate on capacity of DCs excreting IL-12. [Methods] BIU-87 ceils are frozen and melt repeatedly for 4 times, then tumor lysate is obtained. Healthy volunteer PBMCs cultured with RPMI1640 contained rh GM-CS+rh IL-4+rh TNF-α in vitro for 9 days, and then DCs pulse with bladder-tumor lysate. DCs could excrete IL-12, so the supernatant were detected on every 3 days by ELISA technique. [Results] DCs could be harvestd through healthy volunteer PBMCs cultured in vitro. The capacity of DCs excreting IL-12, which sensitized by bladder-tumor lysate, was stronger than that of unsensitized DCs, and the secretory volume were different on the different stages (P 〈0.05). [Conclusion] The secretory volume of IL-12 p70 is affected by full-grown status and some stimulant signals, and bladder-tumor lysate is one of stimulant signals.
作者 杨惠祥 徐勇
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第16期2433-2435,共3页 China Journal of Modern Medicine
关键词 白细胞介素-12 树突状细胞 膀胱癌 生物治疗 IL-12 dendritic cell bladder cancer biological therapy
  • 相关文献

参考文献8

二级参考文献48

  • 1雷晓,雷玉洁,石彦,余佩武,饶芸,钱锋,周立新.胃癌抗原特异性树突状细胞疫苗的抗瘤效应[J].中华实验外科杂志,2004,21(6):755-755. 被引量:3
  • 2曲春枫 顾培绨 鞠吉雨 等.IL-12基因转染的人树突状细胞加强细胞加强细胞反应的体外研究[J].中国免疫学杂志,2000,16:836-840.
  • 3[1]Steinman RM.The dendritic cell system and its role in immunogenicity[J].Annu Rev Immunol,1991,9:271-296.
  • 4[2]Caux C,Vanbervliet B,Massacrier C,et al.B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells[J].J Exp Med,1994,180:1841-1847.
  • 5[3]Inaba K,Witmer-Pack M,Inaba M,et al.The tissue distribution of the B7-2 costimulator in mice:abundant expression on dendritic cells in sim and during maturation in vitro[J].J Exp Med,1994,180:1849-1860.
  • 6[4]Sallusto F,Lanzavecchia A.Efficient presemation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus inter-leukin-4 and downregulated by tumor necrosis factor alpha[J].J Exp Med,1994,179:1109-1118.
  • 7[5]Koch F,Trockenbacher B,Schuler G,et al.Antigen processing capacity of dendritic cells from mice of different MHC backgrounds:down-regulation upon culture and evidence for heterogeneity of dendritic cell populations[J].Adv Exp Med,1995,378:203-206.
  • 8[6]Mayordomo JI,Zorina T,Storkus WJ,et al.Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines[J].Stem Cells,1997,15:94-103.
  • 9[7]Hsu FJ,Benike C,Fagnoni F,et al.Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells[J].Nat Med,1996,2:52-58.
  • 10[8]Timmerman JM,Levy R.Dendritic cell vaccines for cancer immunotherapy[J].Annu Rev Med,1999,50:507-529.

共引文献22

同被引文献15

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部